DCAF13 and neoplasm: Mechanically, DCAF13-CRL4 targets p53 polyubiquitination and proteasomal degradation to inhibit p53 protein stabilization, negatively regulating the tumor-suppressive p53 signaling pathway, altering gene histone modifications, and ultimately promote LUAD cell growth and migration in LUAD.